Longevity & AgingResearch PaperOpen Access

Ether Lipids and Sphingolipids Reveal Sex-Specific Aging Waves in Human Plasma

A 1,030-person lipidomic study uncovers three distinct aging 'crests' and sex-divergent lipid shifts that reshape how we understand biological aging.

Saturday, June 13, 2026 0 views
Published in Redox Biol
Microscopic 3D visualization of phospholipid bilayer membranes glowing with ether-linked molecular structures, split by warm and cool tones for male and female

Summary

Researchers performed targeted lipidomic profiling of 543 lipid species in plasma from 1,030 adults aged 50–98 years. They identified three non-linear aging inflection points ('crests') at ages 55–60, 65–70, and 75–80, with the 65–70 crest predominant in men and the 75–80 crest in women. Ceramides rose then plateaued after age 85, while ether-linked phospholipids and sphingolipids showed the most pronounced age-related changes. These shifts implicate impaired membrane dynamics, reduced antioxidant defense, altered bioenergetics, and disrupted cell signaling. The study underscores that lipid metabolism during aging is fundamentally non-linear and strongly sex-dependent, offering a framework for developing lipidomic biomarkers and targeted longevity interventions.

Deep Dive Audio
0:00--:--

Detailed Summary

Aging reshapes the body's lipid landscape in ways that are far more complex and sex-differentiated than previously appreciated. This study addresses a critical gap: while lipidomics has grown rapidly, large-cohort human studies tracking the full lipidome across decades of adult life remain rare. The researchers set out to systematically map how the circulating lipidome changes from middle age through late life, and to identify sex-specific inflection points that may signal distinct biological transitions.

The team analyzed plasma from 1,030 adults (534 men, 445 women, ages 50–98) from a Spanish cohort, using high-throughput liquid chromatography–triple quadrupole mass spectrometry (LC-QQQ-MS) to quantify 543 lipid species spanning all major lipid classes. Gas chromatography was used to assess circulating fatty acid composition. Statistical models included both robust linear regression and non-linear approaches, adjusting for BMI, blood pressure, cholesterol, comorbidities, and other clinical covariates. Functional indices—double bond index, saturation, average chain length, fluidity, and diversity—were also calculated to capture structural properties of the lipidome.

The most striking finding was the identification of three aging 'crests'—non-linear inflection points at 55–60, 65–70, and 75–80 years—where lipidome composition undergoes accelerated reorganization. Men showed the strongest inflection at 65–70 years, while women's most prominent transition occurred at 75–80 years, likely reflecting post-menopausal metabolic adaptation. Ceramides increased linearly with age across both sexes but plateaued and began declining after approximately age 85. Dehydroceramides decreased while hexosylceramides rose, particularly in women. Sphingomyelin declined in women only. Ether-linked phospholipids (plasmalogens and alkyl species) were among the most affected lipid categories, declining with age and suggesting compromised antioxidant defense and membrane integrity. Acylcarnitines also emerged as a key enriched category, pointing to disrupted fatty acid beta-oxidation and mitochondrial bioenergetics with advancing age.

Functional index analyses revealed age-associated increases in double bond index and fluidity index across multiple lipid classes, alongside reductions in average chain length and saturation—changes consistent with a shift toward less stable, more peroxidation-prone membrane compositions. Lipid diversity increased in several sphingolipid subclasses, suggesting compensatory remodeling. These combined shifts impair at least five functional lipid categories: dynamic membrane properties, bioenergetic efficiency, antioxidant capacity, cellular identity markers, and lipid raft signaling platforms.

The sex-stratified design is a particular strength, revealing that women's lipidome remains more protected—likely hormonally buffered—until later in life, after which a steeper reorganization occurs. This has direct implications for understanding sex differences in age-related disease risk and timing. Caveats include the cross-sectional design, which limits causal inference, and the relatively homogeneous (Spanish, older-adult) population, which may reduce generalizability. Hypolipidemic drug use was assessed as a confounder but found to have minimal independent impact given high overlap with dyslipidemia diagnoses.

Key Findings

  • Three aging 'crests' identified at 55–60, 65–70, and 75–80 years, with sex-specific dominant transitions.
  • Ceramides increase linearly with age in both sexes but plateau and decline after age 85.
  • Ether-linked phospholipids (plasmalogens) decline with aging, signaling reduced antioxidant membrane defense.
  • Women's lipidomic transition peaks 10 years later than men's, likely linked to post-menopausal hormonal changes.
  • Acylcarnitines and sphingolipids are top enriched lipid categories driving age-related metabolic dysfunction.

Methodology

Cross-sectional targeted lipidomic profiling of 1,030 plasma samples using LC-QQQ-MS (543 lipid species) and GC-based fatty acid analysis. Both linear regression and non-linear modeling were applied, with robust adjustment for clinical confounders including BMI, blood pressure, comorbidities, and serum cholesterol fractions.

Study Limitations

The cross-sectional design prevents causal conclusions about lipidome changes driving aging versus reflecting it. The cohort is restricted to Spanish adults aged 50–98, limiting generalizability to other ethnicities and younger populations. Longitudinal follow-up data would be needed to confirm the temporal sequence of the identified aging crests.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.